CLIA Waiver Decisions: FDA Begins Posting Summaries
By Michael Mezher -
Published 03 October 2017
The US Food and Drug Administration (FDA) on Friday began posting decision summaries for its Clinical Laboratory Improvement Amendments (CLIA) waiver decisions for in vitro diagnostics (IVDs) as part of a pilot to boost transparency.
Categories: News, US, FDA, In vitro diagnostics, Submission and registration
Tags: CLIA, CLIA Waiver by Application